CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-04). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2158 · Search date 2026-08-04 · Methodology v0.6

Black tea plus milk,
does it really help with Loss of the tea-associated flow-mediated dilation response?

30-Second Summary
C
Evidence Grade C · 52 · Safety acceptable
Milk lowered black tea's flow-mediated dilation response in small short trials, but cardiovascular events were not studied
No serious signal appeared with the tested tea and milk quantities. Caffeine sensitivity, milk allergy, and lactose intolerance remain separate considerations.
What the
research shows
The grade is C. In an acute crossover study of 16 healthy women, black tea increased two-hour flow-mediated dilation, but adding 10% skim milk removed that rise. A four-week crossover study of 17 healthy adults reported FMD 1.64 percentage points lower with milk tea than with tea. Both were small, short studies of a vascular ultrasound marker, not myocardial infarction or stroke, giving 52 points.
What the
ads claim
Casein-catechin complex formation in vitro and a short-term human vascular response are distinct steps. Neither establishes loss of all long-term cardiovascular prevention or proves that milk tea harms the heart.
*

Useful facts when choosing a product

  • The 2007 trial used 500 mL freshly brewed black tea with 10% skim milk and measured FMD two hours later.
  • Cell and isolated-vessel experiments in the same report found casein-catechin complexes and suppression of tea-related vasorelaxation signaling.
  • In the 2018 four-week trial, milk tea differed from tea by -1.64±0.19 FMD percentage points, but no myocardial infarction or stroke was measured.
  • The 2018 trial had no washout between treatments. Sequence and period were analyzed, but the design did not physically eliminate carryover.
Gap Measurement · Verdict 2158 · C 52
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Lorenz 2007 crossed 16 healthy women through water, 500 mL black tea, and black tea with 10% skim milk, measuring brachial FMD two hours later. Tea increased FMD versus water, while milk removed the rise. Ahmad 2018 randomized 17 healthy adults through four weeks each of water, tea, and milk tea without washout. Tea was +1.00±0.18 points versus water, and milk tea was -1.64±0.19 versus tea. The teams differed, but funding for the second trial could not be confirmed in the accessible record.

02

Why this is classified as C (52)

Acute and four-week crossover studies pointed in the same direction, but evidence remains confined to two small short trials and a surrogate ultrasound marker without strict independent replication, giving C with 52 points.

Counterpoint. Taste, nutritional value, and long-term cardiovascular events are not determined by this ultrasound-marker verdict.

Rejudgment record. Cross-check applied — Accepted same-direction signals from two small crossover studies while accounting for differing duration and design, surrogate endpoint, short follow-up, and unconfirmed funding

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Milk lowers the short-term FMD response to black teaCTwo small crossover trials pointed the same way, but the endpoint is surrogate.
Milk tea increases myocardial infarction or stroke?No combination trial measured clinical events.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Randomized three-condition acute crossover trial16Original funding not confirmedBrachial flow-mediated dilation two hours after intakeTea increased FMD versus water; 10% skim milk removed the increase, P<0.01Direct acute combination trial
Study 2Randomized three-condition four-week crossover trial17Not confirmed in the accessible recordBrachial FMD at the end of each four-week periodTea plus milk versus tea -1.64±0.19 percentage points, P<0.0001Same-direction supporting trial with different duration
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-04).

Lorenz M, Jochmann N, von Krosigk A, et al. Addition of milk prevents vascular protective effects of tea. Eur Heart J. 2007;28(2):219-223. PMID: 17213230. DOI: 10.1093/eurheartj/ehl442.
checked
Ahmad AF, Rich L, Koch H, et al. Effect of adding milk to black tea on vascular function in healthy men and women: a randomised controlled crossover trial. Food Funct. 2018;9(12):6307-6314. PMID: 30411751. DOI: 10.1039/C8FO01019F.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-04 · Corrections: none

Cite this verdict

Black tea plus milk x loss of flow-mediated dilation response Evidence Grade C card
[Chamgap] Black tea plus milk x loss of flow-mediated dilation response — Evidence Grade C·52. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/black-tea-milk-flow-mediated-dilation/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.